Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
New Approaches to Cocaine Abuse Medications
Early Randomized Surgical Epilepsy Trial
Human Breast Cancer Cell Growth Inhibition by Vitamin E
MRI of Coronary Arteries Using Hyperpolarized Helium
Presidential Award for Excellence in Secondary Mathematics (DE)
Recently added grants:
Identification of Veterans at-risk for Suicide: a Multidisciplinary Approach
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
Molecular mechanisms by which mild elevation of mitochondrial superoxide extends lifespan
Protecting Privacy and Facilitating Shared Access of Clinical and Genetic Data of Special Populations
Determinants of prostate cancer sensitivity to PD-1 blockade
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67188-2-0-1
Application #
7574851
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Johns Hopkins University
$228,891
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Girgis, Reda /
$167,061
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant